Where is Diabeloop located?

Diabeloop is headquartered in France.

How many employees does Diabeloop have?

As of Mar 31, 2026, the latest employee count at Diabeloop is 82.

Is Diabeloop a funded company?

Diabeloop is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Diabeloop rank among its competitors?

Diabeloop ranks 1st amongst 32 active competitors, of which 6 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Pacific Diabetes Technologies, which secured $3.38M in Oct, 2025.

Who are the top competitors of Diabeloop?

Diabeloop's top competitors include DreaMed, TypeZero Technologies and Cellnovo. Among them, Pacific Diabetes Technologies secured the most recent funding round in October, 2025.

Diabeloop - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of automated insulin delivery solutions for type 1 diabetes. The company’s self-learning algorithm automates treatment, relieving the burden of constant therapeutic decisions. The algorithm analyzes glucose data and adjusts insulin delivery to maintain target levels. The company partners with insulin pump manufacturers to expand user choice and access.

Website: www.diabeloop.com/
Social
Phone Number: +33 **********

Key Metrics

Founded Year

2015

Location

France

Stage

Late Stage

Total Funding

$50.3M

Investors

BigBooster

Ranked

1^st among 32 active competitors

Employee Count

82 as on Mar 31, 2026

Similar Companies

DreaMed & 40 more

View Diabeloop's full profile

Diabeloop has raised a total funding of $50.3M. Diabeloop has 1 institutional investor.

View details of Diabeloop's funding rounds and investors

The founders of Diabeloop is Erik Huneke.

Here are the details of Diabeloop's key team members:

Erik Huneke: Co-Founder & Co-CEO of Diabeloop.

View details of Diabeloop's Founder profiles and Board Members

Diabeloop's employee count trend

Diabeloop has 82 employees as of Mar 26. Here is Diabeloop's employee count trend over the years:

Uncover Diabeloop's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Diabeloop include DreaMed, TypeZero Technologies and Cellnovo. Here is the list of Top 10 competitors of Diabeloop, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Diabeloop 2015, France, Late Stage	Developer of automated insulin delivery solutions for type 1 diabetes	$50.3M	BigBooster	53/100
2nd	DreaMed 2014, Petah Tikva (Israel), Series A	AI-based clinical decision support system for diabetes management	$8.3M	Medtronic, eHealth Ventures & 3 others	47/100
3rd	TypeZero Technologies 2013, Charlottesville (United States), Acquired	Device for continuous glucose monitoring with manually operated insulin delivery	$415K	Center for Innovative Technology	38/100
4th	Cellnovo 2002, London (United Kingdom), Deadpooled	Smart device for diabetic management	$48.4M	Edmond de Rothschild, Advent Life Sciences ... & 11 others	36/100
5th	Vitadio 2017, Prague (Czech Republic), Series A	Provider of an online information platform for diabetic patients	$4.45M	Theras Group, EIT Health & 3 others	35/100
6th	Steady Health 2017, San Francisco (United States), Acquired	Provider of app to manage diabetes conditions in patients	-	Wave Capital, Living Fund	34/100
7th	BG Monitor 2011, San Francisco (United States), Unfunded	Diabetes management app for easy tracking and insulin calculation	-	-	33/100
8th	LilyLink 2024, San Francisco (United States), Unfunded	Provider of tech-enabled diabetes management programs for prenatal care	-	-	33/100
9th	Hillo 2019, Boulogne billancourt (France), Funding Raised	Provider of clinical decision tool for healthcare professionals	-	Wille Finance, Paris Business Angels & 1 others	33/100
10th	Pacific Diabetes Technologies 2011, Portland (United States), Series A	Innovative diabetes management solutions through a single, integrated device	$6.98M	Helmsley Charitable Trust, NIH & 3 others	32/100